This document addresses good clinical practice for the design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the clinical performance or effectiveness and safety of medical devices. For post-market clinical investigations, the principles set forth in this document are intended to be followed as far as relevant, considering the nature of the clinical investigation (see Annex I). This document specifies general requirements intended to — protect the rights, safety and well-being of human subjects, — ensure the scientific conduct of the clinical investigation and the credibility of the clinical investigation results, — define the responsibilities of the sponsor and principal investigator, and — assist sponsors, investigators, ethics committees, regulatory authorities and other bodies involved in the conformity assessment of medical devices. NOTE 1 Users of this document need to consider whether other standards and/or national requirements also apply to the investigational device(s) under consideration or the clinical investigation. If differences in requirements exist, the most stringent apply. NOTE 2 For Software as a Medical Device (SaMD) demonstration of the analytical validity (the SaMD's output is accurate for a given input), and where appropriate, the scientific validity (the SaMD's output is associated to the intended clinical condition/physiological state), and clinical performance (the SaMD's output yields a clinically meaningful association to the target use) of the SaMD, the requirements of this document apply as far as relevant (see Reference [4]). Justifications for exemptions from this document can consider the uniqueness of indirect contact between subjects and the SaMD. This document does not apply to in vitro diagnostic medical devices. However, there can be situations, dependent on the device and national or regional requirements, where users of this document might consider whether specific sections and/or requirements of this document could be applicable.
Tämän julkaisun valmistelusta Suomessa vastaa Palvelualojen työnantajat PALTA ry, puh. 040 579 4393.
Sisällysluettelo
Foreword
1 Scope
2 Normative references
3 Terms and definitions
4 Summary of good clinical practice (GCP) principles
5 Ethical considerations
5.1 General
5.2 Improper influence or inducement
5.3 Compensation and additional health care
5.4 Registration in publicly accessible database
5.5 Responsibilities
5.6 Communication with the ethics committee (EC)
5.7 Vulnerable populations
5.8 Informed consent
6 Clinical investigation planning
6.1 General
6.2 Risk management
6.3 Justification for the design of the clinical investigation
6.4 Clinical investigation plan (CIP)
6.5 Investigator's brochure (IB)
6.6 Case report forms (CRFs)
6.7 Monitoring plan
6.8 Investigation site selection
6.9 Agreement(s)
6.10 Labelling
6.11 Data monitoring committee (DMC)
7 Clinical investigation conduct
7.1 General
7.2 Investigation site initiation
7.3 Investigation site monitoring
7.4 Adverse events and device deficiencies
7.5 Clinical investigation documents and documentation
7.6 Additional members of the investigation site team
7.7 Subject privacy and confidentiality of data
7.8 Document and data control
7.9 Investigational device accountability
7.10 Accounting for subjects
7.11 Auditing
8 Suspension, termination, and close-out of the clinical investigation
8.1 Completion of the clinical investigation
8.2 Suspension or premature termination of the clinical investigation
8.3 Routine close-out
8.4 Clinical investigation report
8.5 Risk assessment and conclusions
8.6 Document retention
9 Responsibilities of the sponsor
9.1 Clinical quality management
9.2 Clinical investigation planning and conduct
9.3 Outsourcing of duties and functions
9.4 Communication with regulatory authorities
10 Responsibilities of the principal investigator
10.1 General
10.2 Qualification of the principal investigator
10.3 Qualification of investigation site
10.4 Communication with the EC
10.5 Informed consent process
10.6 Compliance with the CIP
10.7 Medical care of subjects
10.8 Safety reporting
Annex A Clinical investigation plan (CIP) (normative)
Annex B Investigator's brochure (IB) (normative)
Annex C Case report forms (CRFs) (informative)
Annex D Clinical investigation report (normative)
Annex E Essential clinical investigation documents (informative)
Annex F Adverse event categorization (informative)
Annex G EC responsibilities (informative)
Annex H Application of ISO 14971 to clinical investigations (informative)